23.09
Schlusskurs vom Vortag:
$23.89
Offen:
$23.93
24-Stunden-Volumen:
442.96K
Relative Volume:
0.91
Marktkapitalisierung:
$1.15B
Einnahmen:
$151.91M
Nettoeinkommen (Verlust:
$-46.03M
KGV:
-22.86
EPS:
-1.01
Netto-Cashflow:
$5.65M
1W Leistung:
+5.19%
1M Leistung:
+5.43%
6M Leistung:
-4.23%
1J Leistung:
+11.76%
Biolife Solutions Inc Stock (BLFS) Company Profile
Firmenname
Biolife Solutions Inc
Sektor
Telefon
(425) 401-1400
Adresse
3303 MONTE VILLA PARKWAY, BOTHELL, WA
Vergleichen Sie BLFS mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
BLFS
Biolife Solutions Inc
|
23.09 | 1.15B | 151.91M | -46.03M | 5.65M | -1.01 |
![]()
ISRG
Intuitive Surgical Inc
|
563.95 | 190.61B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
ALC
Alcon Inc
|
93.25 | 48.17B | 9.91B | 1.02B | 665.00M | 2.05 |
![]()
BDX
Becton Dickinson Co
|
175.34 | 47.86B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
RMD
Resmed Inc
|
247.65 | 35.48B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
COO
The Cooper Companies, Inc.
|
81.76 | 16.11B | 3.90B | 392.30M | 288.10M | 1.95 |
Biolife Solutions Inc Stock (BLFS) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-09-30 | Eingeleitet | H.C. Wainwright | Buy |
2024-04-04 | Eingeleitet | Jefferies | Buy |
2023-07-11 | Eingeleitet | Craig Hallum | Buy |
2022-04-25 | Hochstufung | Oppenheimer | Perform → Outperform |
2021-10-19 | Eingeleitet | B. Riley Securities | Buy |
2021-10-15 | Fortgesetzt | Cowen | Outperform |
2021-05-14 | Herabstufung | The Benchmark Company | Buy → Hold |
2021-03-23 | Hochstufung | The Benchmark Company | Hold → Buy |
2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
2020-09-22 | Herabstufung | Oppenheimer | Outperform → Perform |
2020-09-18 | Eingeleitet | Cowen | Outperform |
2020-08-11 | Herabstufung | The Benchmark Company | Buy → Hold |
2020-07-08 | Bestätigt | Maxim Group | Buy |
2020-02-24 | Eingeleitet | Lake Street | Buy |
2020-02-19 | Eingeleitet | The Benchmark Company | Buy |
2020-02-06 | Fortgesetzt | B. Riley FBR | Buy |
2020-01-08 | Eingeleitet | Stephens | Overweight |
2019-11-21 | Eingeleitet | Oppenheimer | Outperform |
2019-07-22 | Eingeleitet | H.C. Wainwright | Buy |
2017-11-10 | Bestätigt | Maxim Group | Buy |
2017-09-19 | Bestätigt | Maxim Group | Buy |
2017-07-05 | Hochstufung | Janney | Neutral → Buy |
2017-03-10 | Bestätigt | Maxim Group | Buy |
2017-01-19 | Eingeleitet | Maxim Group | Buy |
Alle ansehen
Biolife Solutions Inc Aktie (BLFS) Neueste Nachrichten
UOttawa startup PanThera CryoSolutions sold to U.S. firm in multimillion-dollar deal - Ottawa Business Journal
Can BioLife Solutions (BLFS) Climb 30.68% to Reach the Level Wall Street Analysts Expect? - Yahoo Finance
HC Wainwright Reiterates Buy Rating for BioLife Solutions (BLFS) - GuruFocus
BioLife Solutions, Inc. (NASDAQ:BLFS) Shares Bought by Stifel Financial Corp - Defense World
Biolife solutions reaffirms 2025 revenue guidance at $95.5M–$99M amid cell processing growth - MSN
Brokers Set Expectations for BLFS Q3 Earnings - Defense World
BioLife Solutions (NASDAQ:BLFS) Shares Gap Down – Here’s Why - Defense World
When (BLFS) Moves Investors should Listen - news.stocktradersdaily.com
BioLife Solutions, Inc. (NASDAQ:BLFS) Q1 2025 Earnings Call Transcript - Insider Monkey
BioLife Solutions Inc. Reports Strong Start to 2025 - TipRanks
BioLife Solutions Inc (BLFS) Q1 2025 Earnings Call Highlights: S - GuruFocus
BioLife Solutions Q1 2025 Earnings Call Transcript - MarketBeat
BioLife Solutions Inc (BLFS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance
BioLife Solutions Reports Strong Start to 2025 - TipRanks
BioLife Solutions Inc (BLFS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Strategic Acquisitions - GuruFocus
Beyond the Balance Sheet: What SWOT Reveals About BioLife Solutions Inc (BLFS) - GuruFocus
Earnings call transcript: BioLife Solutions Beats Q1 2025 Expectations By Investing.com - Investing.com UK
Earnings call transcript: BioLife Solutions Beats Q1 2025 Expectations - Investing.com
BioLife Solutions, Inc. (BLFS) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
BioLife Solutions Updates Earnings Call Information - goSkagit
BioLife Solutions Updates Earnings Call Information | BLFS Stock News - GuruFocus
Earnings Flash (BLFS) BioLife Solutions Posts Q1 Revenue $23.9M, vs. FactSet Est of $22.2M - marketscreener.com
BioLife Solutions (BLFS) Reports Strong Q1 Revenue Surpassing Expectations | BLFS Stock News - GuruFocus
BioLife Solutions Reports First Quarter 2025 Financial Results - goSkagit
Balance Sheet Breakdown: Biolife Solutions Inc (BLFS)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX
What To Expect From BioLife Solutions Inc (BLFS) Q1 2025 Earnings - GuruFocus
Dimensional Fund Advisors LP Purchases 40,416 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) - Defense World
Biopreservation Market Review: All Eyes on 2025 Outlook: Helmer Scientific, BioLife Solutions, PrincetonCryo - newstrail.com
BioLife Solutions, Inc. (NASDAQ:BLFS) Shares Sold by Renaissance Technologies LLC - Defense World
Biolife Solutions Inc (BLFS)’s Market Momentum: Closing Strong at 24.11, Down -2.43 - DWinneX
Are Biolife Solutions Inc (BLFS) shares a good deal now? - uspostnews.com
BioLife Solutions to Report First Quarter 2025 Financial Results and Business Update on May 8, 2025 - goSkagit
BioLife Solutions to Report First Quarter 2025 Financial Results - GuruFocus
(BLFS) Investment Report - news.stocktradersdaily.com
BioLife Solutions to Report First Quarter 2025 Financial Results and Business Update on May 8, 2025 | BLFS Stock News - GuruFocus
An Intrinsic Calculation For BioLife Solutions, Inc. (NASDAQ:BLFS) Suggests It's 44% Undervalued - simplywall.st
BioLife Solutions Q1 2025 Earnings: Key Date for Cell Therapy Leaders Financial Update - Stock Titan
BioLife Solutions Inc (BLFS) Trading Down 3.75% on Apr 28 - GuruFocus
BioLife Solutions, Inc. (NASDAQ:BLFS) Receives Average Recommendation of “Buy” from Brokerages - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
BioLife Solutions (NASDAQ:BLFS) Stock Rating Lowered by StockNews.com - Defense World
Wells Fargo & Company MN Boosts Holdings in BioLife Solutions, Inc. (NASDAQ:BLFS) - Defense World
Can Biolife Solutions Inc Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com
What is Biolife Solutions Inc (BLFS) Stock Return on Shareholders’ Capital? - Sete News
Biolife Solutions Inc (BLFS) is an excellent investment, but the stock is overvalued/undervalued right now - uspostnews.com
BioLife Solutions, Inc. (NASDAQ:BLFS) Shares Purchased by Envestnet Asset Management Inc. - Defense World
BioLife Solutions, Inc. (NASDAQ:BLFS) Shares Purchased by Alliancebernstein L.P. - Defense World
LPL Financial LLC Buys 5,308 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) - Defense World
BioLife Solutions, Inc. (NASDAQ:BLFS) Stake Lessened by Geode Capital Management LLC - Defense World
BioLife Solutions, Inc. (NASDAQ:BLFS) Holdings Decreased by JPMorgan Chase & Co. - Defense World
Shareholders have faith in loss-making BioLife Solutions (NASDAQ:BLFS) as stock climbs 8.7% in past week, taking five-year gain to 112% - Yahoo Finance
Finanzdaten der Biolife Solutions Inc-Aktie (BLFS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Biolife Solutions Inc-Aktie (BLFS) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Mathew Aby J. | EVP & Chief Scientific Officer |
Apr 09 '25 |
Sale |
20.11 |
569 |
11,443 |
309,007 |
Aebersold Sarah | Chief Human Resources Officer |
Apr 09 '25 |
Sale |
20.11 |
210 |
4,223 |
79,884 |
Berard Todd | Chief Marketing Officer |
Apr 09 '25 |
Sale |
20.11 |
324 |
6,516 |
135,632 |
Foster Karen A. | Chief Quality and Operations |
Apr 09 '25 |
Sale |
20.11 |
286 |
5,751 |
195,567 |
Aebersold Sarah | Chief Human Resources Officer |
Apr 01 '25 |
Sale |
22.66 |
5,771 |
130,771 |
80,094 |
Berard Todd | Chief Marketing Officer |
Apr 01 '25 |
Sale |
22.66 |
8,902 |
201,719 |
135,956 |
Wichterman Troy | Chief Financial Officer |
Apr 01 '25 |
Sale |
22.66 |
25,687 |
582,067 |
189,242 |
Foster Karen A. | Chief Quality and Operations |
Apr 01 '25 |
Sale |
22.66 |
7,869 |
178,312 |
195,853 |
Mathew Aby J. | EVP & Chief Scientific Officer |
Apr 01 '25 |
Sale |
22.66 |
10,589 |
239,947 |
309,576 |
DuRoss Amy | Director |
Mar 14 '25 |
Sale |
24.96 |
5,632 |
140,575 |
23,811 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):